Trial Results
October 19, 2020
The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
September 14, 2020
A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
July 29, 2020
Learn more about a less intense treatment that preserves throat function and spares unnecessary toxicities
June 10, 2020
The study results, as well as correlative analyses, will be reported in an upcoming medical meeting
